Improved performance within an hour: PLT Health launches synergistic sports nutrition formulation

04 Mar 2020 --- PLT Health Solutions has launched a new formulation of its ingredient Zynamite that has been developed to improve sports performance – in as little as one hour from a single dose. Zynamite PX is a new, patent-pending, synergistic combination of Mangifera indica extract and Sophora japonica extract that offers a unique set of benefits in active/sports nutrition products. The product has been clinically tested and shown to improve peak power output, while reducing lactate build-up and speeding recovery from long, intense workouts. 

“Zynamite PX represents a continuing search for impactful active/sports nutrition ingredients. In 2020, PLT will introduce multiple, exciting, science-backed ingredients to the active/sports market. We want these ingredients to ‘move the needle’ in terms of the type of performance and health benefits consumers can expect,” says Devin Stagg, Chief Operating Officer at PLT Health Solutions.

Click to EnlargePeak power was improved by 3.8 percent in one hour versus placebo in subjects using just one dose of Zynamite PX.“Zynamite PX is one of these with a unique value proposition – it can improve peak power after a single dose in as little as one hour.’ Fast-acting and experiential, Zynamite PX is an ingredient for pre-workout formulations and can also be effective in post-workout recovery-type products. Studies on Zynamite PX also support its use in extreme and endurance sports performance formulations,” he explains.

Back by clinical studies
In 2018, a double-blind cross-over clinical study was conducted to determine whether a single 420 mg dose of Zynamite PX administered one hour before exercise would increase repeated-sprint performance. Subjects performed three Wingate tests interspaced by four minutes and a final 15 second sprint after ischemia. 

Peak power was improved by 3.8 percent in one hour versus placebo in subjects using just one dose of Zynamite PX. One interesting result was that the quercetin dose was about seven times lower than that associated with quercetin ergogenic effects in previous studies, suggesting that this combination may have synergistic effects.

In a second study that looked at athletic recovery, 48 subjects participated in a 10K race followed by 100 drop jumps to elicit exercise-induced muscle damage (EIMD).

Participants took four doses of either Zynamite PX or placebo in 25 hours: a single 420 mg dose of Zynamite PX or placebo one hour before competition, followed by three additional doses every eight hours. Those who took Zynamite PX had attenuated soreness elicited by competitive exercise, and accelerated recovery of muscle performance compared to those who took placebo.

“The extremely rapid increases in performance and recovery after limited use of Zynamite PX are eye-opening. An increase in peak power of 3.8 percent might not seem impressive at first, but it’s important to remember that we’re comparing it to other studies where power results were achieved after much longer periods of supplementation,” says Jeremy Appleton, ND, Director of Medical & Scientific Affairs at PLT.

“And these endpoints were achieved after training, whereas the Zynamite PX had an immediate, demonstrable effect,” he continues. “The same holds true for the recovery benefits associated with Zynamite PX. Taking Zynamite PX just four times in 25 hours produced significant improvement in soreness and ability to exercise compared to placebo. This offers a new type of benefit package to sports nutrition formulators we have not seen before,” he concludes.

By Kristiana Lalou

To contact our editorial team please email us at editorial@cnsmedia.com